The biotechnology and biopharmaceutical sectors feature several pioneering companies leading the research, clinical development, and commercialization of advanced gene therapies. Prominent global leaders include Novartis, Pfizer, Biogen, Sarepta Therapeutics, Alnylam Pharmaceuticals, and BioMarin Pharmaceutical, alongside innovative platform developers like Voyager Therapeutics and bluebird bio. These organizations specialize in utilizing adeno-associated virus vectors, gene-editing technologies, and RNA interference mechanisms to address rare monogenic disorders, neurological conditions, and inherited genetic diseases.